Presentació dels Hospitals
Col·labora

Diagnostics Accelerator and Target ALS Foundation Biomarker Discovery RFP

ALZHEIMER'S DRUG DISCOVERY FOUNDATION (ADDF)

Objecte

Topic: Alzheimer.

Destination: The Diagnostics Accelerator and Target ALS are joining forces to fund biomarker research targeting biomarkers that might be common to disease pathways or pathophysiologies in Alzheimer’s disease, frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) to facilitate biomarker discovery and validation. In doing so, the Diagnostics Accelerator and Target ALS aim to drive towards an improved understanding of the heterogeneity of these neurodegenerative diseases and offer potential solutions for differential diagnosis.
Projects will be funded via two mechanisms:
• Option 1: As a grant through Target ALS Foundation
• Option 2: As a mission-related investment from the Diagnostics Accelerator at the ADDF

Budget: Up to  600,000 $.

Duration: 2 years.

Estàs interessat?

Omple el següent formulari per rebre més informació: